Sep 13, 2026•1 min read
Hecto Group develops AI device for early lung cancer detection and recurrence prediction
Hecto Group’s AI unit, HAI, joined the OnKoTECT consortium led by Seoul National University Bundang Hospital to develop an AI medical device for early lung cancer diagnosis and post‑surgery recurrence prediction, under a Ministry of Trade, Industry and Energy digital‑health project.